Allan RyanApr 82 minModulating the gut microbiome may improve response to ICB therapyDeciphering and modifying the composition of various gut bacteria may improve immune checkpoint blockade (ICB) treatment responses in...
Allan RyanJun 5, 20232 minResearchers investigate why some skin cancers stop responding to therapy at end of lifeChanges in the order, structure, and number of copies of tumour DNA could be the reason some skin cancers ultimately resist treatment,...
John EvansNov 18, 20221 minNivolumab shows promise in advanced cutaneous squamous cell carcinomaFindings from a recent phase II clinical trial show promising results for the immune checkpoint inhibitor nivolumab in the treatment of...
John EvansJan 14, 20222 minSkin reactions may show efficacy of immune checkpoint inhibitorsNew findings suggest the development of cutaneous immune-related adverse events (cirAEs) is associated with better treatment efficacy and...